Aging
Navigate
Submit an Article
Research Paper|Volume 14, Issue 12|pp. 5223–5232
The efficacy of adding hyperthermia to the treatment of advanced NSCLC patients based on the states of EGFR
Back to articleFigure 3(3 of 4)
100%
Figure 3
Figure 3.The subgroups analysis of EGFR mutation between two groups. (A) 1-year OS rates of EGFR mutation between two groups (P>0.05). (B) 1-year PFSfirst rates of EGFR mutation between two groups (P>0.05).